Skip to main content
. 2015 Nov 2;101(1):324–333. doi: 10.1210/jc.2015-2913

Table 1.

Biometric and Endocrine Characteristics in NW and Obese Women at Baseline

NW Women Obese Women Pa
N 12 15
Age, y 28.4 (1.2) 34.8 (1.2) <.01
BMI, kg/m2 21.8 (0.5) 37.8 (1.5) <.01
Weight, kg 59.3 (1.9) 103.8 (6.6) <.01
Waist circumference, cm 73.6 (2.5) 109.1 (2.7) <.01
Waist-hip ratio 0.89 (0.02) 0.90 (0.01) .43
AMH, ng/mL 5.3 (0.9) 4.2 (0.7) .33
Inhibin B, pg/mL 78.6 (7.2) 61.3 (4.8) .0495
Fasting glucose, mg/dL 79.6 (5.5) 90.7 (1.9) .02b
Fasting insulin, mIU/L 8.8 (1.0) 24.2 (7.7) <.01b
HOMA-IR scorec 1.7 (0.2) 5.5 (1.8) <.01b
Plasma N6/N3 ratio 7.7 (0.8) 8.6 (0.4) .36
RBC N6/N3 ratio 5.1 (0.4) 5.4 (0.2) .51
Cycle 1 length, d 27.3 (0.5) 27.6 (0.9) .70
Cycle 2 length, d 28.8 (0.9) 28.5 (1.2) .84
Cycle 3 length, d 28.8 (0.9) 28.1 (1.0) .60

Abbreviations: HOMA-IR, HOMA for insulin resistance; N6/N3, omega-6/omega-3. Values represent mean (standard error of the mean).

a

P values represent two-sample t test, unless otherwise specified.

b

P values represent Mann-Whitney test.

c

HOMA-IR score is a measure of insulin sensitivity, calculated as follows: fasting insulin × fasting glucose/405.